Snowball logo
logo
APLI_logo

Appili Therapeutics Inc

CA$0.005-CA$0.005Β  (50%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20222023202420252026TTM
Revenue
Total revenue
1.3906840.3341770.8274070.1004430.2441790.378807
COGS
0.01260.0062660.01370.01350.0080830.005821
Gross Profit
1.3906840.3279110.8274070.1004430.2360950.372986
Operating Expenses & Income
Operating Income
(24.68)(7.914281)(2.16279)(0.190839)(6.533346)(6.084545)
Total Operating Expenses
24.958.1099922.924540.2912826.7694416.457404
R&D Expenses
21.463.8097085.6222747.3322914.2921654.000728
Selling General & Admin Expenses
4.6128324.438753.0471352.8532112.474752.843041
Earnings from Continuing Operations
Interest Expense
(1.554941)(1.096083)(1.631005)(3.500882)(1.013007)(0.997321)
Interest Income
0.03371.43080.01683.83-0.33424
Income Tax Expense
0.03850.03640.06960.01880.09690.0929
Net Income
Net Income
(25.12)(9.243014)(3.78091)(2.624692)(4.24074)(4.682335)
Supplemental
EBIT
(23.52)(8.110539)(2.080322)0.347106(6.533345)(5.861476)
EBITDA
(23.51)(8.104273)(2.06666)0.360566(6.525262)(5.855655)
In millions of CAD, except % and values per 1 share